Literature DB >> 12904849

Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus.

Véronique Boussaud1, Antoine Parrot, Charles Mayaud, Marie Wislez, Martine Antoine, Clément Picard, Françoise Delisle, Jérome Etienne, Jacques Cadranel.   

Abstract

Three new consecutive cases of life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus are presented, focusing on the particular clinical presentation of this new entity. Between December 1999 and March 2001, three adults aged from 23 to 67 years were admitted to our respiratory intensive care unit for massive hemoptysis and septic shock associated with community-acquired Staphylococcus aureus pneumonia. Isolates were sent to the Centre National de Référence des Toxémies Staphylococciques in Lyon, France, where they were found to secrete Panton-Valentive leukocidin. The clinical course was similar in the three patients, with massive hemoptysis and septic shock necessitating mechanical ventilation. Two patients died rapidly; necropsy showed pulmonary vascular necrosis in one of them. The third patient recovered after appropriate antibiotic therapy. Leukocidin/neutrophil interactions in the pulmonary vasculature may cause severe hemoptysis in patients with community-acquired Staphylococcus aureus pneumonia secreting Panton-Valentine leukocidin. Adult patients with massive hemoptysis and suspected community-acquired pneumonia should receive antibiotic regimens covering Staphylococcus aureus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904849      PMCID: PMC7095030          DOI: 10.1007/s00134-003-1918-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  16 in total

1.  Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes.

Authors:  B König; G Prévost; Y Piémont; W König
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

2.  Prognosis of patients hospitalized with community-acquired pneumonia.

Authors:  M J Fine; J J Orloff; D Arisumi; G D Fang; V C Arena; B H Hanusa; V L Yu; D E Singer; W N Kapoor
Journal:  Am J Med       Date:  1990-05       Impact factor: 4.965

3.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

4.  Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study.

Authors:  P Couppie; B Cribier; G Prévost
Journal:  Arch Dermatol       Date:  1994-09

5.  Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.

Authors:  M Ruiz; S Ewig; M A Marcos; J A Martinez; F Arancibia; J Mensa; A Torres
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

6.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

7.  Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins.

Authors:  G Prevost; P Couppie; P Prevost; S Gayet; P Petiau; B Cribier; H Monteil; Y Piemont
Journal:  J Med Microbiol       Date:  1995-04       Impact factor: 2.472

8.  GTP-binding proteins are involved in the modulated activity of human neutrophils treated with the Panton-Valentine leukocidin from Staphylococcus aureus.

Authors:  T Hensler; M Köller; G Prévost; Y Piémont; W König
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin.

Authors:  Philippe Dufour; Yves Gillet; Michèle Bes; Gerard Lina; François Vandenesch; Daniel Floret; Jerome Etienne; Hervé Richet
Journal:  Clin Infect Dis       Date:  2002-09-03       Impact factor: 9.079

10.  Bacteremic Staphylococcus aureus pneumonia.

Authors:  C Watanakunakorn
Journal:  Scand J Infect Dis       Date:  1987
View more
  19 in total

1.  Favorable outcome of pneumonia due to Panton-Valentine leukocidin-producing Staphylococcus aureus associated with hematogenous origin and absence of flu-like illness.

Authors:  C Alonso-Tarrés; M L Villegas; F J de Gispert; M C Cortés-Lletget; A Rovira Plarromaní; J Etienne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

2.  Methicillin-resistant Staphylococcus aureus in a Canadian intensive care unit: Delays in initiating effective therapy due to the low prevalence of infection.

Authors:  Wendy Sligl; Geoffrey Taylor; Rt Noel Gibney; Robert Rennie; Linda Chui
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-03       Impact factor: 2.471

Review 3.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

4.  Community-acquired necrotizing pneumonia due to methicillin-sensitive Staphylococcus aureus secreting Panton-Valentine leukocidin: a review of case reports.

Authors:  Lukas Kreienbuehl; Emmanuel Charbonney; Philippe Eggimann
Journal:  Ann Intensive Care       Date:  2011-12-22       Impact factor: 6.925

5.  Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease.

Authors:  A Holmes; M Ganner; S McGuane; T L Pitt; B D Cookson; A M Kearns
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

6.  Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.

Authors:  Binh An Diep; Anna Afasizheva; Hoan N Le; Osamu Kajikawa; Gustavo Matute-Bello; Christine Tkaczyk; Bret Sellman; Cedric Badiou; Gerard Lina; Henry F Chambers
Journal:  J Infect Dis       Date:  2013-03-26       Impact factor: 5.226

7.  Severe Hemoptysis Associated with Bacterial Pulmonary Infection: Clinical Features, Significance of Parenchymal Necrosis, and Outcome.

Authors:  Guillaume Carteaux; Damien Contou; Guillaume Voiriot; Antoine Khalil; Marie-France Carette; Martine Antoine; Antoine Parrot; Muriel Fartoukh
Journal:  Lung       Date:  2017-10-12       Impact factor: 2.584

8.  Post-influenza pneumonia caused by the USA300 community-associated methicillin-resistant Staphylococcus aureus in Korea.

Authors:  Kyung Mok Sohn; Doo Ryeon Chung; Jin Yang Baek; So Hyun Kim; Eun-Jeong Joo; Young Eun Ha; Kwan Soo Ko; Cheol-In Kang; Kyong Ran Peck; Jae-Hoon Song
Journal:  J Korean Med Sci       Date:  2012-02-23       Impact factor: 2.153

9.  Methicillin-resistant staphylococcus aureus and community-acquired pneumonia: an evolving relationship.

Authors:  L A Mandell; R Wunderink
Journal:  Clin Infect Dis       Date:  2012-04       Impact factor: 9.079

10.  Prevalence of Genes Encoding Bi-Component Leukocidins among Clinical Isolates of Methicillin Resistant Staphylococcus aureus.

Authors:  Sa Havaei; S Ohadian Moghadam; Mr Pourmand; J Faghri
Journal:  Iran J Public Health       Date:  2010-03-31       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.